Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin in Overweight/Obese Patients with Type 2 Diabetes
NCT00603291Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lorcaserin in obesity, sponsored by Eisai Co., Ltd.. Started Dec 2007; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00603291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603291.